Forecast: Import of Blood, Antisera, Vaccines, Toxins and Cultures to France

The import of blood, antisera, vaccines, toxins, and cultures to France is projected to show a continuous upward trend from 2024 to 2028. Expected values in these years range from $9.2 billion in 2024 to $10.393 billion in 2028. This growth reflects increasing demand in the health sector. However, to provide context, an analysis of the year-on-year percentage change reveals that the import value is forecasted to grow steadily, reflecting roughly a 3% increase annually.

Looking ahead, key trends to watch include advancements in biotechnology and healthcare innovations, which might further accelerate demand for these products. Additionally, policy changes related to healthcare spending and potential supply chain disruptions could impact these forecasts.